• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米材料对健康应用的毒性作用:自动化如何支持文献的系统综述?

Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?

机构信息

Joint Research Centre (JRC), European Commission, Ispra, Italy.

出版信息

J Appl Toxicol. 2022 Jan;42(1):41-51. doi: 10.1002/jat.4204. Epub 2021 May 29.

DOI:10.1002/jat.4204
PMID:34050552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9292569/
Abstract

Systematic reviews of the scientific literature can be an important source of information supporting the daily work of the regulators in their decision making, particularly in areas of innovative technologies where the regulatory experience is still limited. Significant research activities in the field of nanotechnology resulted in a huge number of publications in the last decades. However, even if the published data can provide relevant information, scientific articles are often of diverse quality, and it is nearly impossible to manually process and evaluate such amount of data in a systematic manner. In this feasibility study, we investigated to what extent open-access automation tools can support a systematic review of toxic effects of nanomaterials for health applications reported in the scientific literature. In this study, we used a battery of available tools to perform the initial steps of a systematic review such as targeted searches, data curation and abstract screening. This work was complemented with an in-house developed tool that allowed us to extract specific sections of the articles such as the materials and methods part or the results section where we could perform subsequent text analysis. We ranked the articles according to quality criteria based on the reported nanomaterial characterisation and extracted most frequently described toxic effects induced by different types of nanomaterials. Even if further demonstration of the reliability and applicability of automation tools is necessary, this study demonstrated the potential to leverage information from the scientific literature by using automation systems in a tiered strategy.

摘要

系统评价科学文献可以成为支持监管机构在决策中工作的重要信息来源,特别是在监管经验有限的创新技术领域。纳米技术领域的大量研究活动导致了过去几十年中大量的出版物。然而,即使已发表的数据可以提供相关信息,科学文章的质量往往也参差不齐,几乎不可能以系统的方式手动处理和评估如此大量的数据。在这项可行性研究中,我们研究了开放获取自动化工具在多大程度上可以支持对科学文献中报道的用于健康应用的纳米材料毒性效应进行系统评价。在这项研究中,我们使用了一系列可用的工具来执行系统评价的初始步骤,如目标搜索、数据整理和摘要筛选。这项工作还补充了一个内部开发的工具,该工具使我们能够提取文章的特定部分,例如材料和方法部分或结果部分,我们可以在这些部分进行后续的文本分析。我们根据所报道的纳米材料特性以及提取的不同类型纳米材料引起的最常见毒性效应等质量标准对文章进行了排名。尽管需要进一步证明自动化工具的可靠性和适用性,但这项研究证明了通过在分层策略中使用自动化系统从科学文献中获取信息的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/d3e09419e3a5/JAT-42-41-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/fbc7ded5f4b2/JAT-42-41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/66a5692828f1/JAT-42-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/ffae0b0fac0b/JAT-42-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/9f5f0e7cf4ef/JAT-42-41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/d3e09419e3a5/JAT-42-41-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/fbc7ded5f4b2/JAT-42-41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/66a5692828f1/JAT-42-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/ffae0b0fac0b/JAT-42-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/9f5f0e7cf4ef/JAT-42-41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/9292569/d3e09419e3a5/JAT-42-41-g006.jpg

相似文献

1
Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?纳米材料对健康应用的毒性作用:自动化如何支持文献的系统综述?
J Appl Toxicol. 2022 Jan;42(1):41-51. doi: 10.1002/jat.4204. Epub 2021 May 29.
2
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
5
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
10
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.

引用本文的文献

1
Enhancing the quality and efficiency of regulatory science literature reviews through innovation and collaboration with library and information science experts.通过与图书馆和信息科学专家的创新与合作,提高监管科学文献综述的质量和效率。
Front Med (Lausanne). 2024 Jul 3;11:1434427. doi: 10.3389/fmed.2024.1434427. eCollection 2024.
2
Automation of systematic reviews of biomedical literature: a scoping review of studies indexed in PubMed.生物医学文献系统评价自动化:PubMed 索引研究的范围综述。
Syst Rev. 2024 Jul 8;13(1):174. doi: 10.1186/s13643-024-02592-3.
3
In Vitro Toxicological Insights from the Biomedical Applications of Iron Carbide Nanoparticles in Tumor Theranostics: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Delivering the power of nanomedicine to patients today.今天为患者带来纳米医学的力量。
J Control Release. 2020 Oct 10;326:164-171. doi: 10.1016/j.jconrel.2020.07.007. Epub 2020 Jul 15.
2
Toward systematic review automation: a practical guide to using machine learning tools in research synthesis.迈向系统评价自动化:在研究综合中使用机器学习工具的实用指南。
Syst Rev. 2019 Jul 11;8(1):163. doi: 10.1186/s13643-019-1074-9.
3
Nanomedicines - Tiny particles and big challenges.纳米药物——微小颗粒与巨大挑战。
碳化铁纳米颗粒在肿瘤诊疗中的生物医学应用的体外毒理学见解:一项系统综述和荟萃分析
Nanomaterials (Basel). 2024 Apr 23;14(9):734. doi: 10.3390/nano14090734.
4
Emerging Applications of Nanotechnology in Healthcare and Medicine.纳米技术在医疗保健和医学中的新兴应用。
Molecules. 2023 Sep 14;28(18):6624. doi: 10.3390/molecules28186624.
5
Future perspectives for advancing regulatory science of nanotechnology-enabled health products.推进纳米技术健康产品监管科学的未来展望。
Drug Deliv Transl Res. 2022 Sep;12(9):2145-2156. doi: 10.1007/s13346-022-01165-y. Epub 2022 Jun 12.
Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:23-43. doi: 10.1016/j.addr.2019.06.003. Epub 2019 Jun 19.
4
A question of trust: can we build an evidence base to gain trust in systematic review automation technologies?信任的问题:我们能否建立一个证据基础,以获得对系统评价自动化技术的信任?
Syst Rev. 2019 Jun 18;8(1):143. doi: 10.1186/s13643-019-1062-0.
5
Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials".AAPS 指导论坛关于 FDA 行业指南草案:“包含纳米材料的药物产品,包括生物制品”的报告。
AAPS J. 2019 Apr 17;21(4):56. doi: 10.1208/s12248-019-0329-7.
6
Editorial: Systematic review automation thematic series.社论:系统评价自动化专题系列
Syst Rev. 2019 Mar 11;8(1):70. doi: 10.1186/s13643-019-0974-z.
7
Minimum information reporting in bio-nano experimental literature.生物纳米实验文献的最低信息报告。
Nat Nanotechnol. 2018 Sep;13(9):777-785. doi: 10.1038/s41565-018-0246-4. Epub 2018 Sep 6.
8
Making progress with the automation of systematic reviews: principles of the International Collaboration for the Automation of Systematic Reviews (ICASR).在系统评价自动化方面取得进展:国际系统评价自动化合作(ICASR)的原则。
Syst Rev. 2018 May 19;7(1):77. doi: 10.1186/s13643-018-0740-7.
9
Can systematic reviews contribute to regulatory decisions?系统评价能否为监管决策提供帮助?
Eur J Clin Pharmacol. 2017 Apr;73(4):507-509. doi: 10.1007/s00228-016-2194-y. Epub 2017 Jan 7.
10
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.2016年的纳米医学研究:对目前正在进行临床试验的纳米疗法的综述。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1416. Epub 2016 Jun 16.